FOXP3 and T-cell non-Hodgkin lymphoma: Research has found that FOXP3, although as a marker for T cells, is rarely expressed in healthy cell tissues but is aberrantly upregulated in various malignant tumors, such as lung cancer [53], pancreatic cancer [54], thyroid cancer [55], and T-cell lymphoma [56].